Pharvaris PHVS
NASDAQ PHVS
$30.75 +0.09 (+0.29%)
As of: Oct 22, 2026 · 2:20 PM EDT

Pharvaris (PHVS) Price to Sales (2024 - 2026)

Updated

Analysis

Pharvaris (PHVS) Price to Sales (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.69 Bn 1,140.28 Bn 19.71 Bn
2 Johnson & Johnson 649.22 Bn 569.08 Bn 17.30 Bn
3 AbbVie 504.17 Bn 477.29 Bn 12.70 Bn
4 Merck 366.35 Bn 320.73 Bn 12.21 Bn
5 Novartis Ag 303.54 Bn 267.53 Bn 11.24 Bn
6 Astrazeneca 269.49 Bn 243.18 Bn 12.86 Bn
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn
8 Gilead Sciences 195.09 Bn 169.29 Bn 6.22 Bn
9 Pfizer 172.48 Bn 119.12 Bn 10.94 Bn
10 Pharvaris 1.82 Bn 443.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.02
Mar 31, 2025 0.02
Sep 30, 2024 0.01
API Access

Pharvaris Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=PHVS&period=max&api_key=YOUR_API_KEY